BERLIN (Reuters) -German medical technology firm Brainlab on Tuesday became the latest IPO candidate in the region to put ...

The CEO of German medical technology firm Brainlab said on Tuesday that geopolitical uncertainties had prompted the decision ...

Medical technology company Brainlab postponed its initial public offering in Frankfurt on Tuesday, the latest deal to be ...

German medical technology company’s decision comes after car parts retailer Autodoc pushes back flotation plans ...

Germany's Brainlab postponed its planned initial public offering indefinitely, dealing another blow to Europe's IPO market.

Cirsa’s IPO comprises a €400m primary offering and a €53m secondary offering by LHMC Midco, a holding of Blackstone. Morgan ...

BERLIN, June 30 (Reuters) - German medical technology firm Brainlab is expected to price at 80 euros ($93.86) per share in its initial public offering planned for Thursday, the lower end of its offer ...

Turmoil unleashed by President Donald Trump’s tariffs froze the market for weeks, and while some firms have since launched offerings, others deferred or canceled debuts.Europe’s IPO recovery since has ...

BERLIN (Reuters) -German medical technology firm Brainlab is expected to price at 80 euros ($93.86) per share in its initial public offering planned for Thursday, according to a statement from a ...

Brainlab, the German medical technology company, set the price range for its forthcoming IPO at €80 to €100 a share on Monday ...

Medical technology software firm Brainlab AG and its shareholders are seeking up to €400 million ($460 million) in its Frankfurt initial public offering, as several European companies look to list ...

After the slowest first half for European initial public offerings in more than a decade, dealmakers are banking on several large transactions to reignite the market later this year.